Document:

Form of 2010 Employee Stock or Cash Settled Stock Appreciation Rights Award Agmt

 Exhibit 10.14 
 INCENTIVE PLAN 
 OF 

CARRIZO OIL & GAS, INC. 
 STOCK APPRECIATION RIGHTS AGREEMENT 
 THIS AGREEMENT
(“Agreement”) is made as of the ___ day of July, 2010 (the “Grant Date”), by and between Carrizo Oil & Gas, Inc., a Texas corporation (the “Company”), and _____________ (the “Grantee”). 

The Company has adopted the Incentive Plan of Carrizo Oil & Gas, Inc., as amended and restated effective April 30, 2009
(the “Plan”), a copy of which is appended to this Agreement as Exhibit A and by this reference made a part hereof, for the benefit of eligible employees, directors and independent contractors of the Company and its Subsidiaries.
Capitalized terms used and not otherwise defined herein shall have the meaning ascribed thereto in the Plan. 
 Pursuant to the
Plan, the Committee, which has generally been assigned responsibility for administering the Plan, has determined that it would be in the interest of the Company and its stockholders to grant the stock appreciation rights provided herein in order to
provide Grantee with additional remuneration for services rendered, to encourage Grantee to remain in the employ of the Company or its Subsidiaries and to increase Grantee’s personal interest in the continued success and progress of the
Company. 
 The Company and Grantee therefore agree as follows: 

1. Grant of SAR. Subject to the terms and conditions herein, the Company grants to the Grantee during the period commencing on
July ___, 2010 and expiring at 5 p.m. Houston, Texas time (“Close of Business”) on July ___, 2017 (the “SAR Term”), subject to earlier termination pursuant to paragraph 6 below, a stock appreciation right with respect
to the number of shares of Company Common Stock (“Common Stock”) set forth on Schedule 1 hereto (the “SAR Shares”) with an exercise price set forth on Schedule 1 (the “Exercise Price”). The Exercise Price and SAR
Shares are subject to adjustment pursuant to paragraph 9 below. This stock appreciation right is hereinafter referred to as the “SAR.” 
 2. Conditions of Exercise. The SAR is exercisable only in accordance with the conditions stated in this paragraph. 

(a) Except as otherwise provided in this subparagraph (a), the SAR may only be exercised to the extent the SAR has
become available for exercise in accordance with the following schedule, provided, however, that the SAR shall not be exercisable unless the average daily production of the Company for the calendar quarter ended September 30, 2010
(“3Q10”) is at least (i) 71,726 

  

- 1 - 

 
thousand standard cubic feet equivalent per day (“Mcfe/d”), if the Company’s weighted average realized natural gas price (excluding the impact of cash settled hedges) for 3Q10 is
greater than or equal to $4/Mcf or (ii) 57,381 Mcfe/d, if the Company’s weighted average realized natural gas price (excluding the impact of cash settled hedges) for 3Q10 is less than $4/Mcf: 

 

			
	 Date
	 	 Percentage of SAR

Shares Available for Exercise

	May 29, 2011	 	33.3%
	May 29, 2012	 	33.3%
	May 29, 2013	 	33.3%

 Notwithstanding the
foregoing, subject to the provisions of the applicable written employment agreement between the Grantee and the Company or any Subsidiary (the “Employment Agreement”), the SAR will not be exercisable with respect to any additional SAR
Shares if (i) Grantee has not remained in the continuous employment of the Company and its Subsidiaries through the applicable date. A change of employment is continuous employment within the meaning of this paragraph 2 provided that,
after giving effect to such change, the Grantee continues to be an employee of the Company or any Subsidiary. 

(b) To the extent the SAR becomes exercisable, the SAR may be exercised in whole or in part (at any time or from time to
time, except as otherwise provided herein) until expiration of the SAR Term or earlier termination thereof. 
 3. Manner of
Exercise. The SAR shall be considered exercised (as to the number of SAR Shares specified in the notice referred to in subparagraph (a) below) on the latest of (i) the date of exercise designated in the written notice referred to in
subparagraph (a) below, (ii) if the date so designated is not a business day, the first business day following such date or (iii) the earliest business day by which the Company has received all of the following: 

(a) Written notice, in such form as the Committee may require, designating, among other things, the date of exercise and
the number of SAR Shares with respect to which the SAR is to be exercised; and 
 (b) Any other documentation
that the Committee may reasonably require. 
 4. Mandatory Withholding for Taxes. Grantee acknowledges and agrees that the
Company shall deduct from the cash and/or shares of Common Stock otherwise payable or deliverable upon exercise of the SAR an amount of cash and/or number of shares of Common Stock (valued at their Fair Market Value on the date of exercise) that is
equal to the amount of all federal, state and local taxes required to be withheld by the Company upon such exercise, as determined by the Committee. In the event the Company, in its sole discretion, determines that the Grantee’s tax obligations
will not be satisfied under the methods otherwise expressly 

  

- 2 - 

 
described above, the Grantee authorizes the Company or the Company’s Stock Plan Administrator, currently UBS Financial Services Inc., to (i) sell a number of shares of Common Stock
issued or outstanding pursuant to the Award, which number of shares of Common Stock the Company determines has at least the market value sufficient to meet the tax withholding obligations, plus additional shares of Common Stock to account for
rounding and market fluctuations and (ii) pay such tax withholding to the Company. The shares of Common Stock may be sold as part of a block trade with other Participants such that all Participants receive an average price. 

5. Payment by the Company. As soon as practicable after receipt of all items referred to in paragraph 3, and subject to the
withholding referred to in paragraph 4, the Company shall deliver to the Grantee an amount, in cash, equal to the product of (i) the number of SAR Shares with respect to which the SAR was exercised and (ii) the difference between
(A) the Fair Market Value per share of Common Stock on the date of exercise and (B) the Exercise Price. 
 6.
Termination of Employment. Unless otherwise determined by the Committee in its sole discretion, the SAR shall terminate, prior to the expiration of the SAR Term, at the time specified below: 

(a) If Grantee terminates employment with the Company and its Subsidiaries voluntarily without Good Reason (as defined in
the Employment Agreement), then the SAR shall terminate at the Close of Business on the first business day following the expiration of the 90 day period which began on the date of termination of Grantee’s employment; or 

(b) If Grantee’s employment with the Company and its Subsidiaries is terminated by the Company or a Subsidiary for
Cause (as defined in the Employment Agreement), then the SAR shall terminate immediately upon termination of Grantee’s employment. 
 In any event in which the SAR remains exercisable for a period of time following the date of termination of Grantee’s employment, the SAR may be exercised during such period of time only to the
extent it is or becomes exercisable as provided in paragraph 2. Notwithstanding any period of time referenced in this paragraph 6 or any other provision of this paragraph that may be construed to the contrary, the SAR shall in any event
terminate upon the expiration of the SAR Term. 
 7. Nontransferability of SAR. During Grantee’s lifetime, the SAR
is not transferable (voluntarily or involuntarily) other than pursuant to a qualified domestic relations order as defined by the Code or Title I of the Employee Retirement Income Security Act, or the rules thereunder (a “QDRO”), and,
except as otherwise required pursuant to a QDRO, is exercisable only by the Grantee or Grantee’s court appointed legal representative. The Grantee may designate a beneficiary or beneficiaries to whom the SAR shall pass upon Grantee’s death
and may change such designation from time to time by filing a written designation of beneficiary or beneficiaries with the Committee on the form annexed hereto as Exhibit B or such other form

  

- 3 - 

 
as may be prescribed by the Committee, provided that no such designation shall be effective unless so filed prior to the death of Grantee. If no such designation is made or if the designated
beneficiary does not survive the Grantee’s death, the SAR shall pass by will or the laws of descent and distribution. Following Grantee’s death, the SAR, if otherwise exercisable, may be exercised by the person to whom such SAR passes
according to the foregoing and such person shall be deemed the Grantee for purposes of any applicable provisions of this Agreement. 
 Notwithstanding the foregoing, the SAR is transferable by the Grantee to (i) the children or grandchildren of the Grantee (“Immediate Family Members”), (ii) a trust or trusts for the
exclusive benefit of such Immediate Family Members (“Immediate Family Member Trusts”), or (iii) a partnership or partnerships in which such Immediate Family Members have at least ninety-nine percent (99%) of the equity, profit
and loss interests (“Immediate Family Member Partnerships”). Subsequent transfers of a transferred SAR shall be prohibited except by will or the laws of descent and distribution or pursuant to a QDRO, unless such transfers are made to the
original Grantee or a person to whom the original Grantee could have made a transfer in the manner described herein. No transfer shall be effective unless and until written notice of such transfer is provided to the Committee, in the form and manner
prescribed by the Committee. Following transfer, the SAR shall continue to be subject to the same terms and conditions as were applicable immediately prior to transfer, and, except as otherwise provided herein, the term “Grantee” shall be
deemed to refer to the transferee. The consequences of termination of employment shall continue to be applied with respect to the original Grantee, following which the SAR shall be exercisable by the transferee only to the extent and for the periods
specified in the Plan and this Agreement. 
 8. No Stockholder Rights. The Grantee shall not be deemed for any purpose to
be, or to have any of the rights of, a stockholder of the Company with respect to any shares of Common Stock as to which this Agreement relates. Furthermore, the existence of this Agreement shall not affect in any way the right or power of the
Company or its stockholders to accomplish any corporate act, including, without limitation, the acts referred to in Section 15 of the Plan. 
 9. Adjustments. As provided in Section 15 of the Plan, certain adjustments may be made to the SAR upon the occurrence of events or circumstances described in Section 15 of the Plan.

 10. Restrictions Imposed by Law. Without limiting the generality of Section 16 of the Plan, the Grantee agrees
that Grantee will not exercise the SAR and that the Company will not be obligated to deliver any payment or shares of Common Stock, if counsel to the Company determines that such exercise, payment or delivery would violate any applicable law or any
rule or regulation of any governmental authority or any rule or regulation of, or agreement of the Company with, any securities exchange or association upon which the Common Stock is listed or quoted. The Company shall in no event be obligated to
take any affirmative action in order to cause the exercise of the SAR or the resulting payment or delivery of shares of Common Stock to comply with any such law, rule, regulation or agreement. 

  

- 4 - 

 11. Notice. Unless the Company notifies the Grantee in writing of a different
procedure, any notice or other communication to the Company with respect to this Agreement shall be in writing and shall be (a) delivered personally to the following address: 

Carrizo Oil & Gas, Inc. 

1000 Louisiana St., Suite 1500 
 Houston, Texas 77002 
 or (b) sent by first class mail, postage prepaid and addressed as
follows: 
 Carrizo Oil & Gas, Inc. 

1000 Louisiana St, Suite 1500 
 Houston, Texas 77002 
 Attention: Payroll/Benefits Manager

 Any notice or other communication to the Grantee with respect to this Agreement shall be in writing and shall be delivered personally, or
shall be sent by first class mail, postage prepaid, to Grantee’s address as listed in the records of the Company on the Grant Date, unless the Company has received written notification from the Grantee of a change of address. 

12. Amendment. Notwithstanding any other provisions hereof, this Agreement may be supplemented or amended from time to time as
approved by the Committee as contemplated by Section 6 of the Plan. Without limiting the generality of the foregoing, without the consent of the Grantee, 
 (a) this Agreement may be amended or supplemented (i) to cure any ambiguity or to correct or supplement any provision herein which may be defective or inconsistent with any other provision herein, or
(ii) to add to the covenants and agreements of the Company for the benefit of Grantee or surrender any right or power reserved to or conferred upon the Company in this Agreement, subject, however, to any required approval of the
Company’s stockholders and, provided, in each case, that such changes or corrections shall not adversely affect the rights of Grantee with respect to the Award evidenced hereby without the Grantee’s consent, or (iii) to make
such other changes as the Company, upon advice of counsel, determines are necessary or advisable because of the adoption or promulgation of, or change in or of the interpretation of, any law or governmental rule or regulation, including any
applicable federal or state securities laws; and 
 (b) subject to Section 6 of the Plan and any required
approval of the Company’s stockholders, the Award evidenced by this Agreement may be canceled by the Committee and a new Award made in substitution therefor, provided that the Award so substituted shall satisfy all of the requirements of
the Plan as of the date such new Award is made and no such action shall adversely affect the SAR to the extent then exercisable without the Grantee’s consent. 

  

- 5 - 

 13. Grantee Employment. Nothing contained in this Agreement, and no action of the
Company or the Committee with respect hereto, shall confer or be construed to confer on the Grantee any right to continue in the employ of the Company or any of its Subsidiaries or interfere in any way with the right of the Company or any employing
Subsidiary to terminate the Grantee’s employment at any time, with or without cause; subject, however, to the provisions of the Employment Agreement. 
 14. Governing Law. This Agreement shall be governed by, and construed in accordance with, the internal laws of the State of Texas. 

15. Construction. References in this Agreement to “this Agreement” and the words “herein,” “hereof,”
“hereunder” and similar terms include all Exhibits and Schedules appended hereto, including the Plan. This Agreement is entered into, and the Award evidenced hereby is granted, pursuant to the Plan and shall be governed by and construed in
accordance with the Plan and the administrative interpretations adopted by the Committee thereunder. All decisions of the Committee upon questions regarding the Plan or this Agreement shall be conclusive. Unless otherwise expressly stated herein, in
the event of any inconsistency between the terms of the Plan and this Agreement, the terms of the Plan shall control. The headings of the paragraphs of this Agreement have been included for convenience of reference only, are not to be considered a
part hereof and shall in no way modify or restrict any of the terms or provisions hereof. 
 16. Duplicate Originals. The
Company and the Grantee may sign any number of copies of this Agreement. Each signed copy shall be an original, but all of them together represent the same agreement. 
 17. Rules by Committee. The rights of the Grantee and obligations of the Company hereunder shall be subject to such reasonable rules and regulations as the Committee may adopt from time to time
hereafter. 
 18. Entire Agreement. Subject to the provisions of the Employment Agreement, Grantee and the Company hereby
declare and represent that no promise or agreement not herein expressed has been made and that this Agreement contains the entire agreement between the parties hereto with respect to the SAR and replaces and makes null and void any prior agreements,
oral or written, between Grantee and the Company regarding the SAR. 
 19. Grantee Acceptance. Grantee shall signify
acceptance of the terms and conditions of this Agreement by signing in the space provided at the end hereof and returning a signed copy to the Company. 

  

- 6 - 

							
	ATTEST:	 		 	 Carrizo Oil & Gas, Inc.

				
	  	 		 	By:	 	  
	Secretary	 		 		 	 Name: S. P. Johnson

Title:   President

			
		 		 	ACCEPTED:
			
	 	 		 	 
		 		 	Employee Name

  

  

- 7 - 

			
		 	Schedule 1 to Stock Appreciation Rights
		 	Agreement dated as of July __, 2010

Incentive Plan of Carrizo Oil & Gas, Inc. 

 

			
	 Grantee:
	  	[Employee Name]
		
	 Grant Date:
	  	July __, 2010
		
	 Exercise Price:
	  	$_____ per share
		
	 SAR Shares:
	  	______ shares of Common Stock.

  

- 8 - 

			
		 	Exhibit B to Stock Appreciation Rights
		 	Agreement dated as of July __, 2010

Incentive Plan of Carrizo Oil & Gas, Inc. 
 Designation of Beneficiary 
 I,
_________________________________________________________________ (the “Grantee”), hereby declare 
 that upon my death
______________________________________________________________ (the “Beneficiary”) of 

                       
                                         
    Name 
 _______________________________________________________________________________________________, 

                Street
Address                                
City                                         
   
State                                        
     Zip Code 
  
 who is my
____________________________________________________________, shall be entitled to the 

                         
                       Relationship to Grantee 
 SAR and all other rights accorded the Grantee by the above-referenced agreement (the “Agreement”). 
 It is understood that this Designation of Beneficiary is made pursuant to the Agreement and is subject to the conditions stated herein, including the Beneficiary’s survival of the Grantee’s
death. If any such condition is not satisfied, such rights shall devolve according to the Grantee’s will or the laws of descent and distribution. 
 It is further understood that all prior designations of beneficiary under the Agreement are hereby revoked and that this Designation of Beneficiary may only be revoked in writing, signed by the Grantee,
and filed with the Company prior to the Grantee’s death. 

_______________________________                    
                                         
               ____________________________________ 

                         
   Date                                      
                                         
                                         
             Grantee                         

  

- 9 -Intercompany Cost Plus Agreement

 Exhibit 10.17 
 DEVELOPMENT AGREEMENT 
 This DEVELOPMENT AGREEMENT (the
“Agreement”), dated as of September 26, 2006, with operational effect as of the 1st day of April 2006 ( the “Effective Date”), by and between VRINGO, INC., a corporation organized under the laws of the State of Delaware, United States of
America ( “Vringo” ), and VRINGO (ISRAEL) LTD., a company organized under the laws of the State of Israel (“Subsidiary” ). 

RECITALS 

Whereas, Vringo owns or licenses certain technology including but not limited to technology related to cellular telephone video
ringtones (“Cellular Technology”). 
 Whereas, Vringo desires to retain Subsidiary to perform for
Vringo certain research and development services related to the Cellular Technology from time to time, and Subsidiary is willing to perform such services, on the basis set forth more fully below. 

AGREEMENT 

Now, Therefore, in consideration of the mutual promises, representations, warranties, covenants and conditions set forth in this
Agreement and for other good and valuable consideration, the receipt of which is hereby acknowledged, the parties hereto mutually agree as follows: 
  

	1.	SERVICES 

  

	 	1.1	Projects. Vringo may from time to time request Subsidiary to conduct research and development services on its behalf, which requests may be through
Project Assignments in the form attached hereto as Exhibit A (“Form of Project Assignment”). Subsidiary agrees to provide such research and development services
(“Services”) described in any Project Assignment in a professional and workmanlike manner, according to the schedule of work set forth therein. For the removal of any doubt, it is hereby clarified that Subsidiary agrees that
the terms of this Agreement will apply to all Services performed by Subsidiary for Vringo even if a Project Assignment form has not been completed for a special assignment. 

 

	 	1.2	Performance; No Conflicting Obligations. Subsidiary agrees that it shall act in good faith towards Vringo and that it shall use its best efforts to
complete any Project Assignment according to any specifications provided by Vringo. Subsidiary shall provide reports on a periodic basis, or as reasonably requested by Vringo, regarding the status of the Project Assignments. Subsidiary also agrees
not to perform similar services during the term of this Agreement for any other company competitive with the business of Vringo as presently conducted or as proposed to be conducted unless Vringo gives prior written consent.

  

	 	1.3	 Fees. Vringo shall, upon receipt of an invoice prepared by Subsidiary shortly after the end of each calendar quarter, pay Subsidiary its cost
price and , other than as set forth herein, its overhead costs and out-of-pocket expenses incurred by Subsidiary, including depreciation expenses, actual salaries, duties, and costs, but excluding taxes on income, plus 8% of such total amount, or
such other percentage as the Company shall reasonably determine when revisiting this issue within a 12-24 month period following the Effective Date hereof 

  
 1 

	 	 
(“Fees”). Such Fees will be settled in US Dollars, or as mutually agreed by the parties (“Payments”). In addition, in the event that employees or
consultants of Subsidiary shall be required to travel and perform Services outside of Israel on behalf of Vringo, Vringo shall pay for the living expenses of such employee or consultant, including housing and transportation costs, as agreed between
the parties. To remove any doubt, the term “Fees” shall not include any costs or fees relating to Subsidiary’s start-up and related initial operating expenses. Rather, only those costs and expenses incurred as part of
Subsidiary’s development activities shall constitute “Fees” hereunder. 

  

	2.	PROPRIETARY RIGHTS. 

  

	 	2.1	Proprietary Information. For the purposes of this Agreement, “Proprietary Information” means all designs, technology, algorithms,
ideas, processes, source code, object code, information and know-how contained in, or which form the basis for, the Cellular Technology, including without limitation, any additions, modifications or enhancements, and any supplier lists and all
reproduction, marketing, product development, financial and business information and other proprietary information of Vringo and Vringo’s suppliers. Subsidiary will retain all Proprietary Information in confidence and will use or disclose it
only as permitted by this Agreement. 

  

	 	2.2	Limited Grant. Vringo hereby grants to Subsidiary a non-exclusive, non-transferable, royalty-free license, during the term of this Agreement and subject to the
terms and conditions hereof, to use the Proprietary Information provided by Vringo to Subsidiary solely in the course of proving the Services and solely for the benefit and on behalf of Vringo. Except as stated herein or required to effectuate the
purposes hereof, this Agreement grants Subsidiary no rights to, nor shall any rights be accrued by Subsidiary through Subsidiary’s use of, any inventions, patents, copyrights, know-how, trade secrets, trade names, trademarks (whether registered
or unregistered), or any other rights, franchises or licenses in respect of the Cellular Technology or Proprietary Information. 

  

	 	2.3	Ownership of Inventions. 

  

	 	(i)	 All software innovations, computer programs, code, designs, artwork, notes, documents, information, materials, discoveries, inventions or other
original work, including without limitation, any additions, m9onifications or enhancements, (collectively, the “Intellectual Property”) conceived, discovered, created, authored, or first actually reduced to tangible work
product by Subsidiary either alone or in collaboration with others, which relate in any manner to Subsidiary’s having access to the Cellular Technology or any Proprietary Information, shall be the sole property of Vringo and shall not be in
joint work. Subsidiary and Vringo agree that any patents, trademarks or copyrights and any other rights and interest that may issue relating to any of the Intellectual Property produced by Subsidiary employees or independent contractors while
engaged in such development effort and resulting from Subsidiary’s having access to Proprietary Information shall be in the name of and assigned to Vringo, and Subsidiary further specifically agrees to assign (and does hereby

  
 2 

	 	 
assign) all its rights, title and interest to any and all such Intellectual Property to Vringo. 

  

	 	(ii)	Vringo shall have the sole right to determine the method of protection for any such Intellectual Property, including the right to keep the same as trade secrets, to
file and execute patent applications thereon, to use and disclose the same without prior patent application, to file registrations for copyright or trademarks thereon in its own name or to follow any other procedures that Vringo deems appropriate.

  

	 	(iii)	Subsidiary agrees (i) to disclose promptly and to ensure that the Subsidiary employees or independent contractors engaged in such development effort disclose
promptly in writing to Vringo all such Intellectual Property, and (ii) that Vringo has a power of attorney to apply for in Subsidiary’s name, and to execute any applications and/or assignments reasonably necessary to obtain any patent,
copyright, trademark or other statutory protection for such Designs and Invention in Vringo’s name as Vringo deems appropriate. Subsidiary shall ensure that Subsidiary’s employees and independent contractors engaged in such development
effort waive any and all claims to any right in Intellectual Property created by such employees or independent contractors, and Subsidiary shall be liable to Vringo for damages or losses arising out of Subsidiary’s failure to comply with this
provision. 

  

	 	2.4	Moral Rights. Subsidiary herby irrevocably transfers and assigns to Vringo any and all Moral Rights (as defined below) Subsidiary may have in or with
respect to the Intellectual Property. To the extent Subsidiary cannot assign such rights, Subsidiary hereby waives and agrees never to assert such rights against Vringo or any of Vringo’s licensees. If Subsidiary has any right to the
Intellectual Property that cannot be assigned to Vringo or waived by Subsidiary, Subsidiary unconditionally and irrevocably grants to “Vringo, during the term of such rights, an exclusive, irrevocable, perpetual, worldwide, fully paid and
royalty-free license, with rights to sublicense throughout multiple levels of sublicensees, to reproduce, create derivative works of, distribute, publicly perform and publicly display, by all means now known or later developed such right. In
addition, Subsidiary agrees to obtain such assignment, waiver, covenant not to assert such rights, or license from any subsidiary, subcontractor, or employee who creates, either in whole or part, the Intellectual Property. “Moral
Rights” shall mean any right to (i) divulge a copyrighted work to the public; (ii) retract a copyrighted work from the public; (iii) claim authorship of a copyrighted work; (iv) object to any distortion, mutilation
or other modification of a copyrighted work; or (v) any and all similar rights, existing under judicial or statutory law of any country or jurisdictions in the world, or under any treaty regardless of whether or not such right is called or
generally referred to as a moral right. 

  

	3.	TERM AND TERMINATION. 

  

	 	3.1	Initial Term; Renewal. The initial term of this Agreement shall begin on the Effective Date and continue in force through the fifth anniversary of the date
hereof. Thereafter, this Agreement shall be automatically renewed each year for successive terms of one (1) year unless and until one party provides written notice to the other party at least thirty (30) days prior to the end of such term.

  

	 	3.2	 Termination for Cause. If either party materially defaults in the performance of any provision of this Agreement, the non-defaulting party may
give written notice 

  
 3 

	 	 
to the defaulting party that if the default is not cured within thirty (30) days, the Agreement and the licenses granted hereunder will be terminated and, upon expiration of such period
without cure, this Agreement shall automatically terminate. 

  

	 	3.3	Rights upon Termination. On termination or expiration of this Agreement or the appointments, authorizations and licenses granted hereunder for any reason,
Subsidiary shall immediately destroy or return to Vringo all copies of any Proprietary Information in its possession. 

  

	 	3.4	Survival of Obligations. The provisions of Section 2 (“Proprietary Rights”), and Section 5 (Miscellaneous”) will survive any termination
or expiration of rights under this Agreement. 

  

	4.	WARRANTY AND INDEMNITY. 

  

	 	4.1	Warranty. Subsidiary hereby represents and warrants that (a) all Intellectual Property created or developed by Subsidiary (“Work
Product”) will be an original work of Subsidiary and that any third parties will have executed assignment of rights reasonably acceptable to Vringo; (b) neither the Work Product nor any element thereof will infringe any patent,
copyright, trademark, trade secret, or other proprietary rights of any third party; (c) neither the Work Product nor any element thereof will be subject to any restrictions or to any mortgages, liens, pledges, security interests, encumbrances
or encroachments; (d) Subsidiary will not grant, directly or indirectly, any rights or interest whatsoever in the Work Product to third parties without the express prior written consent of Vringo; (e) Subsidiary has full right and power to
enter into and perform this Agreement without the consent of any third party, and that to the extent any regulatory consents or approvals are required to perform its duties under this Agreement, Subsidiary has secured such consents or approvals;
(f) Subsidiary will take all necessary precautions to prevent injury to any persons or damage to property during the term of this Agreement; and (g) should Vringo permit Subsidiary to use any of Vringo’s equipment, tools, or
facilities during the term of this Agreement, such permission shall be gratuitous and Subsidiary shall be responsible for any injury to any person (including death) or damage to property (including Vringo’s property) arising out of use of such
equipment, tools or facilities, whether or not such claim is based upon its condition or on the alleged negligence of Vringo in permitting its use. Subsidiary further warrants that all Services provided will be of workmanlike quality and Work
Product created will conform to the design or other applicable specifications for such Work Product. 

  

	 	4.2	Indemnity. Subsidiary will indemnify and hold harmless Vringo, its officers, directors, employees, sub-licensees, customers and agents from any and all claims,
losses, liabilities, damages, expenses and costs (including attorneys’ fees and court costs) which result from a breach or alleged breach of any representation or warranty of Subsidiary (a “Claim”) set forth herein
(“Warranty”). Subsidiary shall have no authority to settle or compromise a Claim in any manner which would injure or limit the rights of Vringo without Vringo’s prior written consent, which shall be in Vringo’s sole
and exclusive discretion. Vringo shall have the right to withhold from any payments due to Subsidiary under this Agreement the amount of any defense costs of Vringo, plus additional reasonable amounts as security for Subsidiary’s obligations
under this Paragraph. 

  
 4 

	5.	MISCELLANEOUS. 

  

	 	5.1	Independent Contractor. Subsidiary is an independent contractor and, nothing in this Agreement shall be construed as creating any relationship of partnership,
joint venture, sales agency, or principal and agent. Neither party is the agent of the other, and neither party may hold itself out as such to any third party. Subsidiary has no power or authority to in any way bind Vringo contractually.

  

	 	5.2	Right of Audit. Vringo may from time to time inspect and audit the premises and all the relevant accounting books and records of Subsidiary to ensure compliance
with the terms of this Agreement. Such inspection and audit will be conducted during regular business hours at Subsidiary’s offices and in such a manner as not to interfere with Subsidiary’s normal business activities.

  

	 	5.3	Notices. All notices or reports permitted or required under this Agreement shall be in writing and shall be by personal delivery, telegram, telex, telecopier,
facsimile transmission or by certified or registered mail, return receipt requested, and shall be deemed given upon personal delivery, five (5) days after deposit in the mail, or upon acknowledgement of receipt of electronic transmission.

  

	 	5.4	Assignment. Neither this Agreement nor any rights of Subsidiary hereunder may be assigned by Subsidiary in whole or in part without the prior written approval of
Vringo. For the purposes of this section, a change in the persons or entities who control 50% or more of the equity securities or voting interest of Subsidiary shall be considered an assignment of Subsidiary’s rights. Vringo’s rights and
obligations, in whole or in part, under this Agreement may be assigned by Vringo. Vringo may exercise full transfer and assignment rights in any manner at Vringo’s discretion. 

 

	 	5.5	Governing Law. This Agreement shall be governed in all respects by the laws of the State of New York and of the United States of America as such laws are applied
to agreements entered into and to be performed entirely within New York solely between New York residents. 

  

	 	5.6	Entire Agreement. This Agreement, including the attached Exhibit, constitutes the entire agreement between the parties with respect to the subject matter hereof.
This Agreement supersedes, and the terms of this Agreement govern, any prior agreements. This Agreement may only be changed by mutual agreement of authorized representatives of the parties in writing. 

 

	 	5.7	Modification and Waiver. No supplement, modification, or amendment of this Agreement shall be binging unless executed in writing by the parties hereto. The
failure of either party to require performance by the other party of any provision hereof shall not affect the full right to require such performance at any time thereafter; nor shall the waiver by either party of a breach of any provision hereof be
taken or held to be a waiver of the provision itself. 

  

	 	5.8	Severability. In the event that any provision of this Agreement shall be unenforceable or invalid under any applicable law or be so held by applicable court
decision, such unenforceability or invalidity shall not render this Agreement unenforceable or invalid as a whole, and, in such event, such provision shall be changed and interpreted so as to best accomplish the objectives of such unenforceable or
invalid provision within the limits of applicable law or applicable court decisions. 

  
 5 

	 	5.9	Counterparts. This Agreement may be executed simultaneously in counterparts, each of which shall be deemed to be an original, but all of which together shall
constitute on and the same Agreement. 

  

	 	5.10	Export. Subsidiary acknowledges that the laws and regulations of the United States restrict the export and re-export of certain commodities and technical data of
United States origin, which restrictions may include the Cellular Technology. Subsidiary will not export or re-export the Cellular Technology in contravention of any such laws and regulations. Subsidiary’s obligations pursuant to this section
shall survive and continue after any termination or expiration of rights under this Agreement. 

  

	 	5.11	Paragraph Headings. The section headings appearing in this Agreement are inserted only as a matter of convenience and in no way define, limit, construe or
describe the scope or extent of such section or in any way affect this Agreement. 

 In Witness Whereof, the parties have
executed this Agreement as of the date set forth in the first paragraph hereof. 
  

									
	VRINGO INC.	 		 	VRINGO (ISRAEL) LTD.
					
	Signature:	 	/s/ Jonathan Medved	 		 	Signature:	 	/s/ David Corre
	Print Name:	 	Jonathan Medved	 		 	Print Name:	 	David Corre
	Title:	 	CEO	 		 	Title:	 	VP Finance

  
 6 

 EXHIBIT A 

FORM OF PROJECT ASSIGNMENT 
 The following form should be used when procuring research and development services related to the Cellular Technology for Vringo. As per Section 2.3 (“Ownership of Inventions”), any
work-product from these services will be owned by Vringo, Inc., and will be delivered and assigned (to the extent not automatically assigned pursuant to the Agreement) to Vringo by Subsidiary promptly upon Vringo’s request. 

Project Assignment #____________ 
 (pursuant to that certain Development Agreement dated as of ______ day of April 2006) 
  

					
	 1.      Project. Subsidiary shall render such services as Vringo may from
time to time request in connection with                              .

	
	 2.      Schedule of Work.

	
	 (a)    The work will commence on ________________________ and end on
_________________.

	
	 (b)    Alternatively, the parties have set forth the following performance
milestones:

		
		 	 
		
		 	 
	
	 3.      Fees and Reimbursement. The estimated maximum fee for the project
is $            .

  
 7 

 ASSIGNMENT OF COPYRIGHT 

 

			
	1.	  	For good and valuable consideration, the undersigned assigns and transfers to Vringo, Inc., a Delaware corporation, and its successors and assigns, the copyright in and to the
work (s) listed below which were created by the undersigned ( and not otherwise automatically assigned to Vringo, Inc., pursuant to that certain Development Agreement effective as of the 1st day of April 2006.) and all rights titles and
interests of the undersigned, vested and contingent therein and thereto. Vringo (Israel) Ltd. does not claim any ownership interest in the copyrights assigned hereunder, and this Assignment of Copyright is being provided soloely7 for the purpose of
avoiding any doubt in that regard.
		
	2.	  	List of Work (s):
                                         
                                         
                                         
                                         
    
		
		  	                             
                                         
                                         
                                         
                                         
   .

 Executed as of             
200     
  

			
	VRINGO (ISRAEL) LTD.
		
	Signature:	 	// David Corre
	Print Name:	 	David Corre
	Title:	 	VP Finance

 ACKNOWLEDGED AND
ACCEPTED AS OF
                                        :

 VRINGO INC. 
  

			
	
		
	Signature:	 	// Jonathan Medved
	Print Name:	 	Jonathan Medved
	Title:	 	CEO

  
 8

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00187-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00187-of-00352.parquet"}]]